Taylor, MJ, Freemantle, N, Geddes, JR, Bhagwagar, Z. Early onset of selective serotonin reuptake
inhibitor antidepressant action: systematic review and
meta-analysis. Arch Gen Psychiatry
2006; 63: 1217–23.
Posternak, MA, Zimmerman, M. Is there a delay in the antidepressant effect? A
meta-analysis. J Clin Psychiatry
2005; 66: 148–58.
Harmer, CJ, Shelley, NC, Cowen, PJ, Goodwin, GM. Increased positive versus negative affective
perception and memory in healthy volunteers following selective serotonin
and norepinephrine reuptake inhibition. Am J
2004; 161: 1256–63.
Browning, M, Reid, C, Cowen, PJ, Goodwin, GM, Harmer, C. A single dose of citalopram increases fear
recognition in healthy subjects. J
2007; 21: 684–90.
Harmer, CJ, Bhagwagar, Z, Perrett, DI, Vollm, BA, Cowen, PJ, Goodwin, GM. Acute SSRI administration affects the processing of
social cues in healthy volunteers.
2003; 28: 148–52.
Drevets, WC. Neuroimaging abnormalities in the amygdala in mood
disorders. Ann NY Acad Sci
2003; 985: 420–44.
Sheline, YI, Barch, DM, Donnelly, JM, Ollinger, JM, Snyder, AZ, Mintun, MA. Increased amygdala response to masked emotional
faces in depressed subjects resolves with antidepressant treatment: an
fMRI study. Biol Psychiatry
2001; 50: 651–8.
Fu, CH, Williams, SC, Cleare, AJ, Brammer, MJ, Walsh, ND, Kim, J, et al. Attenuation of the neural response to sad
faces in major depression by antidepressant treatment: a prospective,
event-related functional magnetic resonance imaging
study. Arch Gen Psychiatry
2004; 61: 877–89.
Harmer, CJ, Mackay, CE, Reid, CB, Cowen, PJ, Goodwin, GM. Antidepressant drug treatment modifies the neural
processing of nonconscious threat cues. Biol
2006; 59: 816–20.
Del-Ben, CM, Deakin, JF, McKie, S, Delvai, NA, Williams, SR, Elliott, R, et al. The effect of citalopram pretreatment on
neuronal responses to neuropsychological tasks in normal volunteers: an
FMRI study. Neuropsychopharmacology
2005; 30: 1724–34.
First, MB, Spitzer, RL, Gibbon, M, Williams, JBW. Structured Clinical Interview for DSM–IV Axis I Disorders
(SCID–I). American Psychiatric
Nelson, HE, Willison, J. National Adult Reading Test (NART).
Spielberger, CD, Gorsuch, RL, Lushene, RD. Manual for the State–Trait Anxiety Inventory
(STAI). Consulting Psychologists
Beck, AT, Ward, CH, Mendelson, M, Mock, J, Erbaugh, J. An inventory for measuring
depression. Arch Gen Psychiatry
1961; 4: 561–71.
von Zerssen, D, Strian, F, Schwarz, D. Evaluation of depressive states, especially in
longitudinal studies. Mod Probl
Watson, D, Clark, LA, Tellegen, A. Development and validation of brief measures of
positive and negative affect: the PANAS scales. J
Pers Soc Psychol
1988; 54: 1063–70.
Ekman, P, Friesen, WV. Pictures of Facial Affect.
Consulting Psychologists Press,
Jenkinson, M, Bannister, P, Brady, M, Smith, S. Improved optimization for the robust and accurate
linear registration and motion correction of brain
2002; 17: 825–41.
Smith, SM. Fast robust automated brain
extraction. Hum Brain Mapp
2002; 17: 143–55.
Smith, S. A global optimisation method for robust affine
registration of brain images. Med Image
2001; 5: 143–56.
Beckmann, CF, Jenkinson, M, Smith, SM. General multilevel linear modeling for group
analysis in FMRI. Neuroimage
2003; 20: 1052–63.
Woolrich, MW, Behrens, TE, Beckmann, CF, Jenkinson, M, Smith, SM. Multilevel linear modelling for FMRI group analysis
using Bayesian inference. Neuroimage
2004; 21: 1732–47.
Worsley, KJ, Evans, AC, Marrett, S, Neelin, P. A three-dimensional statistical analysis for CBF
activation studies in human brain. J Cereb Blood
1992; 12: 900–18.
Talairach, J, Tournoux, P. Co-Planar Stereotactic Atlas of the Human Brain.
Lancaster, JL, Woldroff, MG, Parsons, LM, Liotti, M, Freitas, CS, Rainey, L, et al. Automated Talairach atlas labels for function
brain mapping. Hum Brain Mapp
2000; 10: 120–31.
Bhagwagar, Z, Cowen, PJ, Goodwin, GM, Harmer, CJ. Normalization of enhanced fear recognition by acute
SSRI treatment in subjects with a previous history of
depression. Am J Psychiatry
2004; 161: 166–8.
Mogg, K, Bradley, BP. A cognitive-motivational analysis of
anxiety. Behav Res Ther
1998; 36: 809–48.
Morris, JS, Frith, CD, Perrett, DI, Rowland, D, Young, AW, Calder, AJ, et al. A differential neural response in the human
amygdala to fearful and happy facial expressions.
1996; 383: 812–5.
Drevets, WC, Videen, TO, Price, JL, Preskorn, SH, Carmichael, ST, Raichle, ME. A functional anatomical study of unipolar
depression. J Neurosci
1992; 12: 3628–41.
Rauch, SL, Shin, LM, Wright, CI. Neuroimaging studies of amygdala function in anxiety
disorders. Ann NY Acad Sci
Davidson, RJ, Irwin, W, Anderle, MJ, Kalin, NH. The neural substrates of affective processing in
depressed patients treated with venlafaxine. Am J
Stutzmann, GE, LeDoux, JE. GABAergic antagonists block the inhibitory effects
of serotonin in the lateral amygdala: a mechanism for modulation of
sensory inputs related to fear conditioning. J
1999; 19: RC8.
Drevets, WC, Bogers, W, Raichle, ME. Functional anatomical correlates of antidepressant
drug treatment assessed using PET measures of regional glucose
metabolism. Eur Neuropsychopharmacol
2002; 12: 527–44.
Kent, JM, Coplan, JD, Gorman, JM. Clinical utility of the selective serotonin reuptake
inhibitors in the spectrum of anxiety. Biol
1998; 44: 812–24.
Burghardt, NS, Sullivan, GM, McEwen, BS, Gorman, JM, LeDoux, JE. The selective serotonin reuptake inhibitor
citalopram increases fear after acute treatment but reduces fear with
chronic treatment: a comparison with tianeptine.
2004; 55: 1171–8.
Attenburrow, MJ, Williams, C, Odontiadis, J, Reed, A, Powell, J, Cowen, PJ, et al. Acute administration of nutritionally sourced
tryptophan increases fear recognition.
2003; 169: 104–7.
Neumeister, A, Hu, XZ, Luckenbaugh, DA, Schwarz, M, Nugent, AC, Bonne, O, et al. Differential effects of 5-HTTLPR genotypes on
the behavioral and neural responses to tryptophan depletion in patients
with major depression and controls. Arch Gen
2006; 63: 978–86.
Whalen, PJ, Rauch, SL, Etcoff, NL, McInerney, SC, Lee, MB, Jenike, MA. Masked presentations of emotional facial expressions
modulate amygdala activity without explicit knowledge.
1998; 18: 411–8.
Phillips, ML, Williams, LM, Heining, M, Herba, CM, Russell, T, Andrew, C, et al. Differential neural responses to overt and
covert presentations of facial expressions of fear and
2004; 21: 1484–96.
Bishop, SJ, Duncan, J, Lawrence, AD. State anxiety modulation of the amygdala response to
unattended threat-related stimuli. J
2004; 24: 10364–8.
Pessoa, L, McKenna, M, Gutierrez, E, Ungerleider, LG. Neural processing of emotional faces requires
attention. Proc Natl Acad Sci USA
2002; 99: 11458–63.
Wise, RG, Tracey, I. The role of fMRI in drug discovery.
J Magn ResonImaging
2006; 23: 862–76.
Iannetti, GD, Wise, RG. BOLD functional MRI in disease and pharmacological
studies: room for improvement?
Magn Reson Imaging
2007; 25: 978–88.